LGND Ligand Pharmaceuticals
- 120.805
- -2.665-2.16%
Ligand Pharmaceuticals News
144/A: Others
ARS: Annual Report to Security Holders
Ligand Pharmaceuticals | 144/A: Others
Ligand Pharmaceuticals | CT ORDER: Confidential Treatment Order
Ligand Pharmaceuticals | ARS: Annual Report to Security Holders
Ligand Pharmaceuticals | UPLOAD: Others
Ligand Pharmaceuticals | CORRESP: CORRESP
Ligand Pharmaceuticals | UPLOAD: Others
Ligand Pharmaceuticals | SC TO-T/A: Third party tender offer statement (Amendment)
Ligand Pharmaceuticals | CORRESP: CORRESP
Ligand Pharmaceuticals | SC TO-T/A: Third party tender offer statement (Amendment)
Ligand Pharmaceuticals | SC TO-T/A: Third party tender offer statement (Amendment)
Ligand Pharmaceuticals | SC TO-T: Third party tender offer statement
Ligand Pharmaceuticals | SC TO-C: Written communication relating to an issuer or third party tender offer
Ligand Pharmaceuticals | SC TO-C: Written communication relating to an issuer or third party tender offer
Ligand Pharmaceuticals | CT ORDER: Confidential Treatment Order
Ligand Pharmaceuticals | CT ORDER: Confidential Treatment Order
Ligand Pharmaceuticals | PRER14A: Preliminary revised proxy soliciting materials
Ligand Pharmaceuticals | CT ORDER: Confidential Treatment Order
Ligand Pharmaceuticals | CT ORDER: Confidential Treatment Order
Analysis
Price Target
No Data
No Data